Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-01-15 4:30 pm Purchase |
2025-01-10 | 13G | Pacira BioSciences, Inc. PCRX |
MILLENNIUM MANAGEMENT LLC | 2,338,369 5.100% |
2,338,369 (New Position) |
Filing History |
| 2024-02-13 5:12 pm Purchase |
2023-12-29 | 13G | Pacira BioSciences, Inc. PCRX |
The Vanguard Group | 5,098,424 10.980% |
173,229 (+3.52%) |
Filing History |
| 2024-01-19 2:40 pm Purchase |
2023-12-31 | 13G | Pacira BioSciences, Inc. PCRX |
BLACKROCK INC BLK |
8,113,714 17.500% |
862,806 (+11.90%) |
Filing History |
| 2023-02-14 1:31 pm Sale |
2022-12-30 | 13G | Pacira BioSciences, Inc. PCRX |
Macquarie Group Limited | 2,037,049 4.440% |
-2,168,473 (-51.56%) |
Filing History |
| 2023-02-09 11:30 am Purchase |
2022-12-30 | 13G | Pacira BioSciences, Inc. PCRX |
The Vanguard Group | 4,925,195 10.730% |
259,240 (+5.56%) |
Filing History |
| 2023-01-23 3:52 pm Purchase |
2022-12-31 | 13G | Pacira BioSciences, Inc. PCRX |
BLACKROCK INC BLK |
7,250,908 15.800% |
429,390 (+6.29%) |
Filing History |
| 2022-03-02 11:54 am Sale |
2022-02-28 | 13G | Pacira BioSciences, Inc. PCRX |
BAILLIE GIFFORD & CO | 2,170,707 4.840% |
-184,533 (-7.83%) |
Filing History |
| 2022-02-14 10:05 am Purchase |
2021-12-31 | 13G | Pacira BioSciences, Inc. PCRX |
Macquarie Group Limited | 4,205,522 9.440% |
1,452,880 (+52.78%) |
Filing History |
| 2022-02-10 5:22 pm Sale |
2021-12-31 | 13G | Pacira BioSciences, Inc. PCRX |
Renaissance Technologies LLC | 1,849,197 4.150% |
-775,862 (-29.56%) |
Filing History |
| 2022-02-10 08:32 am Purchase |
2021-12-31 | 13G | Pacira BioSciences, Inc. PCRX |
The Vanguard Group | 4,665,955 10.470% |
298,689 (+6.84%) |
Filing History |
| 2022-01-27 5:13 pm Unchanged |
2021-12-31 | 13G | Pacira BioSciences, Inc. PCRX |
BLACKROCK INC BLK |
6,821,518 15.300% |
0 (Unchanged) |
Filing History |
| 2022-01-27 09:49 am Purchase |
2021-12-31 | 13G | Pacira BioSciences, Inc. PCRX |
BAILLIE GIFFORD & CO | 2,355,240 5.290% |
2,355,240 (New Position) |
Filing History |
| 2022-01-26 09:16 am Sale |
2021-12-31 | 13G | Pacira BioSciences, Inc. PCRX |
BLACKROCK INC BLK |
6,821,518 15.300% |
-278,329 (-3.92%) |
Filing History |
| 2021-02-12 08:40 am Purchase |
2020-12-31 | 13G | Pacira BioSciences, Inc. PCRX |
Macquarie Group Limited | 2,752,642 6.340% |
680,468 (+32.84%) |
Filing History |
| 2021-02-10 12:04 pm Purchase |
2020-03-04 | 13G | Pacira BioSciences, Inc. PCRX |
Renaissance Technologies LLC | 2,625,059 6.040% |
2,625,059 (New Position) |
Filing History |
| 2021-02-10 11:40 am Purchase |
2020-12-31 | 13G | Pacira BioSciences, Inc. PCRX |
The Vanguard Group | 4,367,266 10.050% |
22,712 (+0.52%) |
Filing History |
| 2021-02-05 07:51 am Purchase |
2020-12-31 | 13G | Pacira BioSciences, Inc. PCRX |
BLACKROCK INC BLK |
7,099,847 16.300% |
95,348 (+1.36%) |
Filing History |